Protagonist Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.478; its P/E ratio is -19.57; Protagonist Therapeutics is scheduled to report earnings on May 1, 2024, and the estimated EPS forecast is $1.19. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 60.00M	-	-	-	$ 123.00K
Gross Profit	$ 60.00M	-	-	-	$ 123.00K
EBIT	$ 27.34M	$ -34.10M	$ -38.46M	$ -33.73M	$ -36.45M
EBITDA	$ 26.82M	$ -34.28M	$ -38.60M	$ -34.15M	$ -36.52M
Net Income Common Stockholders	$ 27.34M	$ -34.10M	$ -38.46M	$ -33.73M	$ -34.19M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 341.63M	$ 320.73M	$ 313.38M	$ 230.79M	$ 237.34M
Total Assets	$ 357.95M	$ 330.02M	$ 320.45M	$ 239.86M	$ 251.72M
Total Debt	$ 1.14M	$ 1.80M	$ 2.45M	$ 3.06M	$ 3.66M
Net Debt	$ -340.49M	$ -318.92M	$ -310.94M	$ -227.72M	$ -233.69M
Total Liabilities	$ 21.27M	$ 27.87M	$ 26.40M	$ 23.69M	$ 247.88M
Stockholders Equity	$ 336.68M	$ 302.15M	$ 294.11M	$ 216.17M	$ 215.56M
Cash Flow	-
Free Cash Flow	$ 16.94M	$ -27.02M	$ -26.41M	$ -34.36M	$ -31.70M
Operating Cash Flow	$ 16.96M	$ -26.61M	$ -26.24M	$ -34.35M	$ -31.64M
Investing Cash Flow	$ -61.29M	$ -13.56M	$ 25.76M	$ 9.83M	$ 3.94M
Financing Cash Flow	$ 527.00K	$ 35.31M	$ 108.17M	$ 26.46M	$ 553.00K

Currency in USD

Protagonist Therapeutics Earnings and Revenue History

Income Statement >

Protagonist Therapeutics Debt to Assets

Balance Sheet >

Protagonist Therapeutics Cash Flow

Cash Flow >

Protagonist Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing